scispace - formally typeset
Open AccessJournal Article

Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes.

TLDR
Hydroxylation of C-7 in delta6-THC does not alter inhibitory potency, but its oxidation to an acid and aromatization of ring A greatly reduce affinity, which is critical for inhibition of NE, 5-HT and GABA uptake.
Abstract
We have examined the effect of Delta1-tetrahydrocannabinol (delat1-THC) and 12 of its derivatives on the uptake of 3H-labeled norepinephrine (NE), dopamine (DA), serotonin (5-HT) gamma-aminobutyric acid (GABA) into synaptosomes in homogenates of various regions of rat brain. Delta1-THC inhibits the accumulation of NE and 5-HT into hypothalamic preparations and DA into the corpus striatum with Ki values of about 12 to 25 muM while GABA uptake into cerebral cortical preparations is inhibited less (Ki = 140 muM). The affinities of delta6-THC, 7-hydroxy-delta1-THC, 7-hydroxy-delta6-THC and cannabidiol for 5-HT, NE and GABA transports are similar to values for delta1-THC, while cannabigerol, cannabinol and delta6-THC-7-oic acid have substantially less affinity. Thus, hydroxylation of C-7 in delta6-THC does not alter inhibitory potency, but its oxidation to an acid and aromatization of ring A greatly reduce affinity. The hydroxyl at C-3(1) of ring C is critical for inhibition of NE, 5-HT and GABA uptake, since its acetylation or methylation abolishes activity. Inhibition of NE, DA, 5-HT and GABA uptake by all cannabinoids examined is noncompetitive. Only about 1% of delta1-THC and delta6-THC and 5% of cannabidiol are fully soluble under our experimental conditions.

read more

Citations
More filters
Patent

Therapeutic uses of cannabigerol

TL;DR: In this paper, the use of the cannabinoid cannabigerol (CBG) in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from concurrent agonism of the CBi and the CB2 cannabinoid receptors.
Journal ArticleDOI

Cannabis for Pain and Headaches: Primer.

TL;DR: Phytocannabinoids have been identified as key compounds involved in analgesia and anti-inflammatory effects and other compounds found in cannabis such as flavonoids and terpenes are also being investigated as to their individual or synergistic effects.
Journal ArticleDOI

Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

TL;DR: Additional research is warranted to decipher the mechanisms involved, since cannabis use is being legalized increasingly and Δ9-tetrahydrocannabinol and its synthetic analogue nabilone are indicated for the treatment of various disease states.
Journal ArticleDOI

Chronic marijuana smoke exposure in the rhesus monkey. IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats.

TL;DR: In the rat in vivo study, it is found no significant changes in MCh or other neurotransmitter receptor binding in hippocampus, frontal cortex or caudate nucleus after acute or chronic exposure to THC, and in the monkey brain, there are no alterations in the concentration of neurotransmitters.
Journal ArticleDOI

Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms.

TL;DR: In this paper, the authors investigated reasons for use and self-reported therapeutic effects in CBG-predominant cannabis users, and adverse effects including withdrawal symptoms were also explored.
Related Papers (5)
Trending Questions (1)
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum

The paper does not mention the inhibition of adenosine uptake by cannabinoids. It only mentions the inhibition of dopamine uptake in the corpus striatum.